Nagendran Ramalingam, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| alpha-Synuclein | 13 | 2023 | 724 | 2.470 |
Why?
|
| Parkinson Disease | 10 | 2023 | 2774 | 1.030 |
Why?
|
| beta-Synuclein | 2 | 2021 | 14 | 0.990 |
Why?
|
| Dictyostelium | 4 | 2019 | 75 | 0.700 |
Why?
|
| Cell Membrane | 3 | 2021 | 3744 | 0.670 |
Why?
|
| Stearoyl-CoA Desaturase | 4 | 2022 | 86 | 0.560 |
Why?
|
| Microfilament Proteins | 4 | 2016 | 1152 | 0.490 |
Why?
|
| Inclusion Bodies | 3 | 2021 | 279 | 0.480 |
Why?
|
| Locomotion | 1 | 2015 | 378 | 0.440 |
Why?
|
| Fetal Proteins | 1 | 2010 | 94 | 0.370 |
Why?
|
| Membrane Lipids | 1 | 2010 | 248 | 0.350 |
Why?
|
| Carrier Proteins | 5 | 2019 | 5019 | 0.310 |
Why?
|
| Phospholipids | 1 | 2010 | 781 | 0.290 |
Why?
|
| Neurons | 5 | 2021 | 9325 | 0.270 |
Why?
|
| ras GTPase-Activating Proteins | 2 | 2016 | 101 | 0.260 |
Why?
|
| Phosphorylation | 4 | 2023 | 8436 | 0.250 |
Why?
|
| Gene Products, tat | 1 | 2004 | 120 | 0.240 |
Why?
|
| Actins | 5 | 2019 | 2120 | 0.230 |
Why?
|
| gamma-Synuclein | 1 | 2021 | 10 | 0.210 |
Why?
|
| Neuroblastoma | 2 | 2020 | 1225 | 0.210 |
Why?
|
| Thiadiazoles | 1 | 2020 | 55 | 0.190 |
Why?
|
| Rats | 5 | 2023 | 24265 | 0.180 |
Why?
|
| Serine | 1 | 2023 | 828 | 0.180 |
Why?
|
| Chemokines | 1 | 2004 | 954 | 0.170 |
Why?
|
| Amino Acid Sequence | 7 | 2023 | 13814 | 0.170 |
Why?
|
| Microtubules | 3 | 2016 | 1090 | 0.170 |
Why?
|
| Lysine | 1 | 2023 | 1008 | 0.170 |
Why?
|
| Pyridazines | 1 | 2020 | 201 | 0.160 |
Why?
|
| NIH 3T3 Cells | 4 | 2016 | 677 | 0.160 |
Why?
|
| Guanabenz | 1 | 2018 | 6 | 0.160 |
Why?
|
| Lentivirus | 1 | 2021 | 501 | 0.160 |
Why?
|
| Contractile Proteins | 1 | 2019 | 246 | 0.160 |
Why?
|
| Antiparkinson Agents | 1 | 2018 | 183 | 0.150 |
Why?
|
| Activating Transcription Factor 4 | 1 | 2018 | 81 | 0.150 |
Why?
|
| Adrenergic alpha-2 Receptor Agonists | 1 | 2018 | 87 | 0.150 |
Why?
|
| Protein Binding | 3 | 2021 | 9387 | 0.140 |
Why?
|
| Mesencephalon | 1 | 2018 | 327 | 0.140 |
Why?
|
| Myosin Type II | 1 | 2015 | 68 | 0.130 |
Why?
|
| Protozoan Proteins | 2 | 2015 | 827 | 0.130 |
Why?
|
| Nuclear Proteins | 1 | 2010 | 5851 | 0.130 |
Why?
|
| Melanoma, Experimental | 1 | 2019 | 559 | 0.130 |
Why?
|
| Actomyosin | 1 | 2015 | 111 | 0.130 |
Why?
|
| Microtubule-Associated Proteins | 3 | 2016 | 1086 | 0.120 |
Why?
|
| Phosphatidylinositols | 1 | 2015 | 291 | 0.120 |
Why?
|
| Animals | 17 | 2023 | 168561 | 0.120 |
Why?
|
| Temperature | 1 | 2021 | 2207 | 0.120 |
Why?
|
| Fatty Acids | 1 | 2022 | 1806 | 0.120 |
Why?
|
| Small Molecule Libraries | 1 | 2019 | 721 | 0.120 |
Why?
|
| Conserved Sequence | 3 | 2021 | 1202 | 0.110 |
Why?
|
| Actin Capping Proteins | 1 | 2012 | 3 | 0.110 |
Why?
|
| Protein Conformation | 2 | 2019 | 4013 | 0.110 |
Why?
|
| Hippocampus | 1 | 2023 | 3661 | 0.100 |
Why?
|
| Amyloid beta-Peptides | 1 | 2023 | 3574 | 0.090 |
Why?
|
| Solubility | 2 | 2023 | 1083 | 0.090 |
Why?
|
| Drug Discovery | 1 | 2018 | 1057 | 0.090 |
Why?
|
| Protein Structure, Tertiary | 2 | 2010 | 3847 | 0.090 |
Why?
|
| Metabolomics | 1 | 2018 | 1467 | 0.090 |
Why?
|
| Lipid Metabolism | 1 | 2018 | 1887 | 0.090 |
Why?
|
| Models, Molecular | 2 | 2019 | 5454 | 0.090 |
Why?
|
| Polymerization | 1 | 2010 | 163 | 0.090 |
Why?
|
| Cytosol | 2 | 2023 | 901 | 0.090 |
Why?
|
| Mutation | 5 | 2023 | 29717 | 0.080 |
Why?
|
| Rabbits | 1 | 2015 | 4886 | 0.080 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2018 | 1860 | 0.080 |
Why?
|
| Lipids | 1 | 2019 | 3302 | 0.080 |
Why?
|
| Enzyme Inhibitors | 1 | 2018 | 3800 | 0.080 |
Why?
|
| Lewy Body Disease | 2 | 2020 | 226 | 0.070 |
Why?
|
| Protein Interaction Domains and Motifs | 2 | 2021 | 474 | 0.070 |
Why?
|
| rhoA GTP-Binding Protein | 2 | 2019 | 241 | 0.070 |
Why?
|
| HIV-1 | 1 | 2004 | 6934 | 0.070 |
Why?
|
| Cell Movement | 2 | 2019 | 5212 | 0.070 |
Why?
|
| Protein Multimerization | 2 | 2021 | 971 | 0.060 |
Why?
|
| Mice | 9 | 2023 | 81045 | 0.060 |
Why?
|
| Cell Proliferation | 1 | 2020 | 10472 | 0.060 |
Why?
|
| Enzyme Activation | 1 | 2010 | 3701 | 0.060 |
Why?
|
| tat Gene Products, Human Immunodeficiency Virus | 1 | 2004 | 127 | 0.060 |
Why?
|
| Phylogeny | 3 | 2008 | 2797 | 0.060 |
Why?
|
| Cell Death | 2 | 2020 | 1695 | 0.060 |
Why?
|
| AIDS Dementia Complex | 1 | 2004 | 152 | 0.060 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 1 | 2023 | 407 | 0.050 |
Why?
|
| Cell Line | 3 | 2019 | 15994 | 0.050 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 2004 | 442 | 0.050 |
Why?
|
| Binding Sites | 1 | 2010 | 6115 | 0.050 |
Why?
|
| rho GTP-Binding Proteins | 2 | 2014 | 293 | 0.050 |
Why?
|
| Chemotaxis | 1 | 2004 | 607 | 0.050 |
Why?
|
| Lipoylation | 1 | 2020 | 64 | 0.050 |
Why?
|
| Up-Regulation | 2 | 2020 | 4211 | 0.040 |
Why?
|
| Oleic Acid | 1 | 2018 | 85 | 0.040 |
Why?
|
| Diglycerides | 1 | 2018 | 176 | 0.040 |
Why?
|
| Oxidopamine | 1 | 2018 | 169 | 0.040 |
Why?
|
| Adrenergic Agents | 1 | 2018 | 70 | 0.040 |
Why?
|
| Peptide Fragments | 1 | 2010 | 5095 | 0.040 |
Why?
|
| PC12 Cells | 1 | 2018 | 330 | 0.040 |
Why?
|
| Transcriptional Activation | 1 | 2004 | 1782 | 0.040 |
Why?
|
| Mutagenesis | 1 | 2021 | 1263 | 0.040 |
Why?
|
| Protein Phosphatase 1 | 1 | 2018 | 137 | 0.040 |
Why?
|
| Luminescent Proteins | 1 | 2020 | 853 | 0.040 |
Why?
|
| Lewy Bodies | 1 | 2017 | 133 | 0.040 |
Why?
|
| Mice, Transgenic | 2 | 2019 | 9735 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 3 | 2018 | 21821 | 0.030 |
Why?
|
| Cell Polarity | 1 | 2019 | 644 | 0.030 |
Why?
|
| Disease Models, Animal | 3 | 2019 | 18006 | 0.030 |
Why?
|
| Microscopy, Electron | 1 | 2019 | 2645 | 0.030 |
Why?
|
| Mutation, Missense | 1 | 2004 | 2556 | 0.030 |
Why?
|
| Humans | 12 | 2023 | 742088 | 0.030 |
Why?
|
| Fibroblasts | 2 | 2016 | 4143 | 0.030 |
Why?
|
| Monocytes | 1 | 2004 | 2593 | 0.030 |
Why?
|
| Protein Structure, Secondary | 1 | 2017 | 1245 | 0.030 |
Why?
|
| Nerve Degeneration | 1 | 2018 | 748 | 0.030 |
Why?
|
| Muscle Contraction | 1 | 2019 | 1241 | 0.030 |
Why?
|
| Lysophospholipids | 1 | 2016 | 331 | 0.030 |
Why?
|
| High-Throughput Screening Assays | 1 | 2019 | 944 | 0.030 |
Why?
|
| Thiazolidines | 1 | 2012 | 74 | 0.030 |
Why?
|
| Protein Stability | 1 | 2014 | 556 | 0.030 |
Why?
|
| Cells, Cultured | 2 | 2019 | 19223 | 0.030 |
Why?
|
| Depsipeptides | 1 | 2012 | 94 | 0.030 |
Why?
|
| Neural Stem Cells | 1 | 2018 | 847 | 0.020 |
Why?
|
| Triglycerides | 1 | 2018 | 2450 | 0.020 |
Why?
|
| Homeostasis | 1 | 2022 | 3335 | 0.020 |
Why?
|
| Signal Transduction | 3 | 2023 | 23387 | 0.020 |
Why?
|
| Epigenesis, Genetic | 1 | 2023 | 3639 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 2017 | 2699 | 0.020 |
Why?
|
| Caenorhabditis elegans | 1 | 2018 | 1416 | 0.020 |
Why?
|
| Genes, Dominant | 1 | 2012 | 880 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2023 | 14554 | 0.020 |
Why?
|
| Tyrosine | 1 | 2012 | 1460 | 0.020 |
Why?
|
| DNA Damage | 1 | 2018 | 2423 | 0.020 |
Why?
|
| Integrins | 1 | 2012 | 845 | 0.020 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2018 | 2749 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2018 | 8300 | 0.020 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2018 | 1728 | 0.020 |
Why?
|
| Molecular Targeted Therapy | 1 | 2018 | 2723 | 0.020 |
Why?
|
| Bacterial Proteins | 1 | 2020 | 3843 | 0.020 |
Why?
|
| Glutamic Acid | 1 | 2012 | 1167 | 0.020 |
Why?
|
| Maltose-Binding Proteins | 1 | 2006 | 62 | 0.020 |
Why?
|
| Gene Expression Regulation | 2 | 2018 | 12071 | 0.020 |
Why?
|
| Molecular Sequence Data | 2 | 2008 | 18112 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2020 | 16665 | 0.010 |
Why?
|
| Protein Isoforms | 1 | 2008 | 1727 | 0.010 |
Why?
|
| Models, Biological | 1 | 2019 | 9581 | 0.010 |
Why?
|
| Cerebral Cortex | 1 | 2018 | 5705 | 0.010 |
Why?
|
| Sequence Alignment | 1 | 2006 | 2257 | 0.010 |
Why?
|
| Apoptosis | 1 | 2018 | 9715 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2006 | 3770 | 0.010 |
Why?
|
| Female | 1 | 2015 | 379592 | 0.010 |
Why?
|